Nexrutine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2018
02420042018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Colon cancer is the third most common cause of death in the United States. Therefore, new preventive strategies are warranted for… (More)
Is this relevant?
2015
2015
Phellodendron amurense bark extract (Nexrutine®) has shown a favorable effect on prostate cancer in vivo and in vitro. We… (More)
Is this relevant?
2015
2015
Novel agents are desperately needed for improving the quality of life and 5-year survival to more than 30% for metastatic… (More)
Is this relevant?
2014
2014
Breast cancers that are estrogen receptor (ER) negative or are ER negative with ErbB2/HER-2 overexpression have a poor prognosis… (More)
Is this relevant?
2014
2014
The dismal 5-year survival (<5%) for pancreatic cancer (PanCA) underscores the need for developing effective therapeutic options… (More)
Is this relevant?
2009
2009
BACKGROUND Epidemiological and laboratory studies support the hypothesis that several plant components influence prostate… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
PURPOSE Development of prostate cancer prevention strategies is an important priority to overcome high incidence, morbidity, and… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2007
2007
We recently showed that Nexrutine, a Phellodendron amurense bark extract, suppresses proliferation of prostate cancer cell lines… (More)
Is this relevant?
2006
2006
Evidence from epidemiological studies suggests that plant-based diets can reduce the risk of prostate cancer. However, very… (More)
Is this relevant?
2004
2004
Humans have two isoforms of Prostaglandin H Synthase or cyclooxygenase: COX-1 and COX-2. COX-1 is cytoprotective. COX-2… (More)
Is this relevant?